Pharmacokinetics of selective serotonin reuptake inhibitors.
about
Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involvedSerotonin synthesis, release and reuptake in terminals: a mathematical modelGetting the balance right: Established and emerging therapies for major depressive disordersInhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetineThe Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary CareThe Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?Placental transfer of antidepressant medications: implications for postnatal adaptation syndromeQuantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetineProgress and prospects in pharmacogenetics of antidepressant drugs.Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder.Summary of information on human CYP enzymes: human P450 metabolism data.Cardiovascular safety profile of dapoxetine during the premarketing evaluation.A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.Tolerability and safety of fluvoxamine and other antidepressants.Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysisFluoxetine: juvenile pharmacokinetics in a nonhuman primate model.Premature ejaculation associated with citalopram withdrawal.Vesicular signalling and immune modulation as hedonic fingerprints: proteomic profiling in the chronic mild stress depression model.Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation.The use of antidepressant and antipsychotic drugs in elderly epilepsy patients.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.Dapoxetine, a novel selective serotonin transport inhibitor for the treatment of premature ejaculationDapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculationTramadol for premature ejaculation: a systematic review and meta-analysis.Cyclic-AMP mediated regulation of ABCB mRNA expression in mussel haemocytesSerotonergic modulation of visceral sensation: lower gut.Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder.Serotonergic lesions of the periaqueductal gray, a primary source of serotonin to the nucleus paragigantocellularis, facilitate sexual behavior in male ratsAdvances in the development of genetic markers for the diagnosis of disease and drug response.Emerging treatments for premature ejaculation: focus on dapoxetine.The pharmacokinetics of sertraline in overdose and the effect of activated charcoal.Drug-metabolizing cytochrome P450s in the brain.Development of potent dopamine-norepinephrine uptake inhibitors (DNRIs) based on a (2S,4R,5R)-2-benzhydryl-5-((4-methoxybenzyl)amino)tetrahydro-2H-pyran-4-ol molecular template.Mother-infant antidepressant concentrations, maternal depression, and perinatal eventsThe AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants.The novel trisubstituted pyran derivative D-142 has triple monoamine reuptake inhibitory activity and exerts potent antidepressant-like activity in rodents.Late-stage clinical development in lower urogenital targets: sexual dysfunction.Metabolic drug interactions with new psychotropic agents.
P2860
Q21129279-9DA46373-C16E-4FF1-860D-7EB9C085DAD2Q21245218-5A11F3DB-508A-4848-8545-DA2813DF49C3Q24610225-0C5C9D76-4700-4EF9-ABB5-9D8A1D5DADD6Q24670560-6843F7D2-BFA4-4849-8D13-D03819984A9EQ24682953-A303FFB8-51E1-4047-9880-F8ABF571533EQ26741187-EA125A96-B513-4EBA-8FE3-C69AEAC8FD70Q26999391-41D65E5A-7963-4DC5-8696-0ED88F40614AQ28543995-2ACF3A02-B46C-4D5A-A475-D4EDC9E7D1DAQ30249569-DC5F5454-CCAD-4F12-8D62-0C692E480D71Q30459493-B7676661-0281-4933-AA3E-2BA8C8F747C8Q31121208-6D93902A-F4E1-49F4-B614-8CA6B2E5E54AQ32103802-0A016345-01D5-403C-993B-4C785C19C912Q33159832-28C63932-C639-43B5-8561-52F66ED462CCQ33718185-C5FDEB62-3E96-4795-9B3D-66A2D8F1ADE5Q33874819-7FCFD914-6ADC-4C09-9CF9-1D24049F2885Q33995120-2F3D3E52-1BAE-4C85-8090-2555B0C85026Q34144128-8CB08C83-C6E8-4269-BEB1-522184EDFD60Q34250302-FDB65A6E-BD11-48AD-ACBD-A2822F459A34Q34278401-A49AE5F2-D8DE-4F6E-97D6-7A37C349EBD7Q34471643-063F2682-3389-4080-9B29-DC1259BC2C6EQ34565008-6FD1DCC1-1602-4AD5-BC85-78AEA4A307F6Q34570611-DA5F979B-5A97-408E-AE35-17452794B66DQ34578945-E15C7262-3790-4F70-B350-268EDE83B498Q34589643-ED1A31D0-64BF-4A27-A605-1F277C75AC26Q34635746-78472D23-F611-44DA-8FBD-9A5C3ADC94ADQ34667751-026E641D-66AD-4BEA-869B-6F2F8A5267D7Q34675010-2A16FA12-2096-4D53-98D9-8DAFF92201C6Q34699859-F738103B-4577-431D-8368-E2BB8BF96534Q34706944-8C666406-56DE-4302-9917-5B6EAF8D2BC8Q34728923-F99B36CD-0283-47BF-AA09-813C7013B8A5Q34884611-06A46008-D7D2-402E-AE13-DCD3F2B78158Q34989184-596095CE-B5CF-467B-B5FF-E4BEB6A4166EQ35023742-82399A5D-8F78-4F19-9CCF-2B6B11CF6659Q35030396-F9313FE6-F985-41F4-ABFB-8AC28F529D14Q35054544-03A51A2D-B0A8-4687-8E14-BBA17D2C3213Q35172179-57D9D5C0-1E7B-406C-913E-56CEF4C205B4Q35236618-4B07F08F-662F-4D15-8026-B539175EF5E8Q35532003-FB6B6BD2-81C3-48C3-B968-EC6E044731A5Q35545741-1D7C3461-0231-4DE0-B6D1-631AF1CA256FQ35619640-95142E29-807C-4465-99DC-F98EC9282FE2
P2860
Pharmacokinetics of selective serotonin reuptake inhibitors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pharmacokinetics of selective serotonin reuptake inhibitors.
@ast
Pharmacokinetics of selective serotonin reuptake inhibitors.
@en
type
label
Pharmacokinetics of selective serotonin reuptake inhibitors.
@ast
Pharmacokinetics of selective serotonin reuptake inhibitors.
@en
prefLabel
Pharmacokinetics of selective serotonin reuptake inhibitors.
@ast
Pharmacokinetics of selective serotonin reuptake inhibitors.
@en
P1476
Pharmacokinetics of selective serotonin reuptake inhibitors.
@en
P2093
P356
10.1016/S0163-7258(99)00048-0
P577
2000-01-01T00:00:00Z